May 9 |
Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
|
May 7 |
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
May 6 |
Vera Therapeutics, Inc.'s (NASDAQ:VERA) high institutional ownership speaks for itself as stock continues to impress, up 5.0% over last week
|
Apr 23 |
Health Care Roundup: Market Talk
|
Apr 13 |
Could This Stock Be the Next Biotech Buyout?
|
Apr 12 |
Insider Sells at Vera Therapeutics Inc: SVP, Finance, Chief Accounting Officer Joseph Young ...
|
Apr 11 |
Vertex Pharmaceuticals to buy Alpine Immune Sciences in $4.9B deal
|
Apr 5 |
ARS Pharmaceuticals, Nuvalent, and More Stocks See Action From Activist Investors
|
Apr 3 |
Vera Therapeutics: Waiting For A Pullback
|
Apr 2 |
Vera Therapeutics Announces Two Oral Presentations at the 61st European Renal Association Congress
|